Clinical Trials Logo

Clinical Trial Summary

In this clinical trial, participants with nerve pain after shingles or nerve injury will receive injections with NT 201 or placebo. The purpose is to measure the decrease of nerve pain with NT 201 compared to placebo. Trial details include: - Trial duration: 22-23 weeks; - Treatment duration: 1 injection visit with a 20-week follow-up period; - Visit frequency: 2 remote visits by phone/video call (1 week and 12 weeks after the injection); 2 on-site visits (6 weeks and 20 weeks after the injection).


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT06091020
Study type Interventional
Source Merz Pharmaceuticals GmbH
Contact Contact Point Clinical Trials
Phone +49 69 1503 3030
Email ctis@merz.de
Status Recruiting
Phase Phase 2
Start date November 22, 2023
Completion date April 2025